The details of the partnership were not disclosed.
“We are very excited to be working with Children’s Hospital of Philadelphia to explore better treatment options for patients with hypoplastic left heart syndrome,” said Timothy Nelson, MD, PhD, director of the Todd and Karen Wanek Family Program at the Mayo Clinic. “By entering into this collaboration, we are making it possible for all children with hypoplastic left heart syndrome to be able to participate in cell-based treatments, no matter their location. This new hypoplastic left heart syndrome consortium significantly expands the reach of hypoplastic left heart syndrome research.”
“Children’s Hospital of Philadelphia has a long-standing history of caring for children with hypoplastic left heart syndrome, and this exciting collaboration with Mayo Clinic offers promising opportunities to develop new ways to give patients an even better quality of life,” said Robert Shaddy, MD, chief of cardiology at the Children’s Hospital of Philadelphia.
More articles on transactions and valuations:
Stonewall Jackson CEO: Mon Health merger will be good for community
St. Luke’s Hospital transition to independent facility ‘hectic but fruitful’ after split with ProMedica
21 recent hospital transactions and partnerships
